|
FINAL TIMETABLE
Thursday, May 18, 2006
|
|||||||||||||||||||||||||||||||||||||||||
|
3 Parallel Halls |
||
08:30 – 09:15 |
PLENARY Mechanisms of conversion of atherosclerosis into atherothrombotic syndromes |
|
|
09:15 – 10:00 |
PLENARY Identifying novel genetic determinants of hemostatic balance |
||
10:00 – 10:30 |
Coffee break, Exhibition and Posters |
||
10:30 – 12:00 |
ANTIPHOSPHOLID SYNDROME The infectious origin of APS from Rheumatic fever to Libman Sacks endocarditis Diagnosis of antiphospholipid syndrome Catastrophic antiphospholipid syndrome Role of anti-beta2 glycoprotein I antibodies in Antiphospholipid Syndrome-associated thrombosis: In vitro and in vivo studies |
WOMEN’S ISSUES ORAL PRESENTATIONS |
STROKE AND NUTRITION ORAL PRESENTATIONS |
12:00 – 13:30 |
Lunch break, Exhibition and Posters |
||
13:30 – 15:00 |
NOVEL THERAPIES IN CARDIOLOGY Myocardial regeneration Clopidogrel Resistance What's next in antiplatelet therapies
|
VASCULAR BIOLOGY ORAL PRESENTATIONS |
INHERITED BLEEDING DISORDERS IN MIDDLE EASTERN POPULATIONS Pathophysiology of hypercoagulable state in mediterranean anemia (Thalassemia) Coagulation disorders in Iran Hemostatic disorders in Jordan Glanzmann thrombasthenia in Jews and Arabs in Israel and Palestine |
15:00 – 15:30 |
Coffee break, exhibition and posters |
||
15:30 – 17:00 |
BLEEDING DISORDERS Several rare inherited bleeding disorders are relatively common in Israel From clinical and molecular characterization to a treatment of rare bleeding disorders Molecular basis of fibrinogen disorders |
TREATMENT OF VTE ORAL PRESENTATIONS |
INFLAMMATION ORAL PRESENTATIONS |
|
|